H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 104 Citations 30,826 347 World Ranking 3189 National Ranking 1841

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Diabetes mellitus
  • Surgery

His main research concerns Randomized controlled trial, Visual acuity, Surgery, Type 1 diabetes and Diabetes mellitus. The various areas that Roy W. Beck examines in his Randomized controlled trial study include Anesthesia, Atropine, Clinical trial and Optic neuritis. His biological study spans a wide range of topics, including Diabetic retinopathy and Ranibizumab.

His work is dedicated to discovering how Surgery, Optic nerve are connected with Ischemia and other disciplines. His Type 1 diabetes research incorporates elements of Research design, Insulin, Young adult and Pediatrics. His study focuses on the intersection of Diabetes mellitus and fields such as Internal medicine with connections in the field of Endocrinology and Glucose meter.

His most cited work include:

  • Screening Depressed Patients in Family Practice: A Rapid Technic (1539 citations)
  • Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis (1302 citations)
  • Continuous glucose monitoring and intensive treatment of type 1 diabetes. (1089 citations)

What are the main themes of his work throughout his whole career to date?

Roy W. Beck mostly deals with Type 1 diabetes, Diabetes mellitus, Internal medicine, Randomized controlled trial and Surgery. His Type 1 diabetes research incorporates themes from Hypoglycemia, Insulin, Glycemic, Research design and Pediatrics. His research integrates issues of Endocrinology and Type 2 diabetes in his study of Internal medicine.

His Randomized controlled trial study combines topics in areas such as Anesthesia, Atropine, Clinical trial and Ophthalmology, Visual acuity. His research investigates the connection between Ophthalmology and topics such as Diabetic retinopathy that intersect with problems in Macular edema. His work carried out in the field of Surgery brings together such families of science as Cornea and Optic neuritis.

He most often published in these fields:

  • Type 1 diabetes (35.36%)
  • Diabetes mellitus (34.71%)
  • Internal medicine (24.95%)

What were the highlights of his more recent work (between 2017-2021)?

  • Diabetes mellitus (34.71%)
  • Type 1 diabetes (35.36%)
  • Internal medicine (24.95%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Diabetes mellitus, Type 1 diabetes, Internal medicine, Glycemic and Hypoglycemia. The study incorporates disciplines such as Young adult, Pediatrics and Family medicine in addition to Diabetes mellitus. His Type 1 diabetes research includes themes of Research design, Randomized controlled trial, Insulin and Gerontology.

His Randomized controlled trial study integrates concerns from other disciplines, such as Physical therapy, Ranibizumab, Crossover study and Visual acuity. Roy W. Beck has researched Internal medicine in several fields, including Endocrinology and Type 2 diabetes. His studies deal with areas such as Intervention, Brief intervention, Urology and Insulin delivery as well as Glycemic.

Between 2017 and 2021, his most popular works were:

  • Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (499 citations)
  • State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018 (396 citations)
  • Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials. (168 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Diabetes mellitus
  • Surgery

Roy W. Beck mainly focuses on Diabetes mellitus, Glycemic, Type 1 diabetes, Internal medicine and Hypoglycemia. His research investigates the link between Diabetes mellitus and topics such as Intensive care medicine that cross with problems in Diabetes management. In general Glycemic study, his work on Continuous glucose monitoring often relates to the realm of Usability, thereby connecting several areas of interest.

His Type 1 diabetes research includes themes of Research design, Insulin and Gerontology. In Hypoglycemia, Roy W. Beck works on issues like Pediatrics, which are connected to Severe hypoglycemia, Diabetes Control and Complications Trial and Glucose meter. The concepts of his Randomized controlled trial study are interwoven with issues in Ranibizumab and Visual acuity.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Screening Depressed Patients in Family Practice: A Rapid Technic

Aaron T. Beck;Roy W. Beck.
Postgraduate Medicine (1972)

2345 Citations

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis

L D Jacobs;R W Beck;J H Simon;R P Kinkel.
The New England Journal of Medicine (2000)

1918 Citations

Continuous glucose monitoring and intensive treatment of type 1 diabetes.

William V. Tamborlane;Roy W. Beck;Bruce W. Bode;Bruce Buckingham.
The New England Journal of Medicine (2008)

1714 Citations

Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

Michael J. Elman;Lloyd Paul Aiello;Roy W. Beck;Neil M. Bressler.
Ophthalmology (2010)

1498 Citations

A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis

Roy W. Beck;Patricia A. Cleary;Malcolm M. Anderson;John L. Keltner.
The New England Journal of Medicine (1992)

1315 Citations

Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry

Kellee M. Miller;Nicole C. Foster;Roy W. Beck;Richard M. Bergenstal.
Diabetes Care (2015)

1102 Citations

Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.

John A Wells;Adam R Glassman;Allison R Ayala.
The New England Journal of Medicine (2015)

972 Citations

International Consensus on Use of Continuous Glucose Monitoring

Thomas Danne;Revital Nimri;Tadej Battelino;Richard M. Bergenstal.
Diabetes Care (2017)

827 Citations

Hopelessness, depression, and attempted suicide.

Kenneth Minkoff;Eric Bergman;Aaron T. Beck;Roy Beck.
American Journal of Psychiatry (2006)

824 Citations

The Effect of Corticosteroids for Acute Optic Neuritis on the Subsequent Development of Multiple Sclerosis

Beck Rw;Cleary Pa;Trobe Jd;Kaufman Di.
The New England Journal of Medicine (1993)

757 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Roy W. Beck

David M. Maahs

David M. Maahs

Stanford University

Publications: 108

William V. Tamborlane

William V. Tamborlane

Yale University

Publications: 102

Timothy W. Jones

Timothy W. Jones

Tennessee Department of Health

Publications: 82

Maria A. Oquendo

Maria A. Oquendo

Columbia University

Publications: 75

Eileen E. Birch

Eileen E. Birch

Retina Foundation of the Southwest

Publications: 73

Bruce A. Buckingham

Bruce A. Buckingham

Stanford University

Publications: 73

Xavier Montalban

Xavier Montalban

Autonomous University of Barcelona

Publications: 71

Maureen G. Maguire

Maureen G. Maguire

University of Pennsylvania

Publications: 68

Claudio Cobelli

Claudio Cobelli

University of Padua

Publications: 64

Elliot M. Frohman

Elliot M. Frohman

The University of Texas at Austin

Publications: 63

Laura J. Balcer

Laura J. Balcer

New York University

Publications: 63

J. John Mann

J. John Mann

Columbia University

Publications: 62

Irl B. Hirsch

Irl B. Hirsch

University of Washington

Publications: 62

Mauri Marttunen

Mauri Marttunen

University of Helsinki

Publications: 59

Elizabeth A. Davis

Elizabeth A. Davis

University of Western Australia

Publications: 59

Moshe Phillip

Moshe Phillip

Tel Aviv University

Publications: 56

Something went wrong. Please try again later.